Evidence map›Paper›PMID 38536232›Full record

ArticleJMIR formative research2024

Adapting mHealth Interventions (PrEPmate and DOT Diary) to Support PrEP Retention in Care and Adherence Among English and Spanish-Speaking Men Who Have Sex With Men and Transgender Women in the United States: Formative Work and Pilot Randomized Trial.

Albert Y Liu, Cat-Dancing Alleyne, Susanne Doblecki-Lewis, Kimberly A Koester, Rafael Gonzalez, Janie Vinson, Hyman Scott, Susan Buchbinder, Thiago S Torres

Open access · goldAbstract read
In one paragraph

Article in JMIR formative research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. User Input in the Development of Digital Sexual Health Tools: A Scoping Review and Guidance for Tool Developers.Health expectations : an international journal of public participation in health care and health policy · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Albert Y LiuBridge HIV, San Francisco Department of Public Health, San Francisco, CA, United States.ORCID https://orcid.org/0000-0003-0320-823X
Cat-Dancing AlleyneBridge HIV, San Francisco Department of Public Health, San Francisco, CA, United States.ORCID https://orcid.org/0009-0003-8710-053X
Susanne Doblecki-LewisDepartment of Medicine, University of Miami Miller School of Medicine, Miami, FL, United States.ORCID https://orcid.org/0000-0001-6535-6698
Kimberly A KoesterDepartment of Medicine, University of California, San Francisco, San Francisco, CA, United States.ORCID https://orcid.org/0000-0003-0023-1127
Rafael GonzalezBridge HIV, San Francisco Department of Public Health, San Francisco, CA, United States.ORCID https://orcid.org/0009-0006-7269-463X
Janie VinsonBridge HIV, San Francisco Department of Public Health, San Francisco, CA, United States.ORCID https://orcid.org/0009-0001-4944-7415
Hyman ScottBridge HIV, San Francisco Department of Public Health, San Francisco, CA, United States.ORCID https://orcid.org/0000-0001-8775-7214
Susan BuchbinderBridge HIV, San Francisco Department of Public Health, San Francisco, CA, United States.ORCID https://orcid.org/0000-0003-2404-0712
Thiago S TorresInstituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.ORCID https://orcid.org/0000-0002-2557-601X
University of California, San Francisco · USSan Francisco Department of Public Health · USInstituto Evandro Chagas · BRUniversity of Miami · US

Funding

Ujima Mentoring ProgramP30MH062246 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALLORY O JOHNSON · 2001 to 2026
$57.4M
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit (FioTrials)UM1AI069476 · NIAID · FUNDACAO OSWALDO CRUZ · PI BEATRIZ GRINSZTEJN · 2012 to 2026
$26.3M
Randomized Trial to Optimize Virologic Suppression Rates Using a Point-of-Care Urine Monitoring Assay (ROVING-PUMA)R01AI143340 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Monica Gandhi · 2018 to 2026
$5.6M
NIAID NIH HHS R01 AI143340NIAID NIH HHS UM1 AI069476NIMH NIH HHS P30 MH062246
6 · The paper itself

Abstract

backgroundA growing number of mobile health (mHealth) technologies are being developed to support HIV preexposure prophylaxis (PrEP) adherence and persistence; however, most tools have focused on men who have sex with men (MSM), and few are available in Spanish. To maximize the potential impact of these tools in reducing gender and racial/ethnic disparities and promoting health equity, mHealth tools tailored to Spanish-speaking people and transgender women are critically needed.

objectiveThe aim of this study is to adapt and tailor 2 mHealth technologies, PrEPmate and DOT Diary, to support daily PrEP adherence and persistence among Spanish-speaking MSM and English- and Spanish-speaking transgender women and to evaluate the feasibility and acceptability of these tools.

methodsPrEPmate, an interactive, bidirectional, text messaging intervention that promotes personalized communication between PrEP users and providers, and DOT Diary, a mobile app that promotes self-management of PrEP use and sexual health through an integrated electronic pill-taking and sexual activity diary, were previously developed for English-speaking MSM. We conducted 3 focus groups with 15 English- and Spanish-speaking transgender women and MSM in San Francisco and Miami to culturally tailor these tools for these priority populations. We then conducted a 1-month technical pilot among 21 participants to assess the usability and acceptability of the adapted interventions and optimize the functionality of these tools.

resultsParticipants in focus groups liked the "human touch" of text messages in PrEPmate and thought it would be helpful for scheduling appointments and asking questions. They liked the daily reminder messages, especially the fun facts, gender affirmations, and transgender history topics. Participants recommended changes to tailor the language and messages for Spanish-speaking and transgender populations. For DOT Diary, participants liked the adherence tracking and protection level feedback and thought the calendar functions were easy to use. Based on participant recommendations, we tailored language within the app for Spanish-speaking MSM and transgender women, simplified the sexual diary, and added motivational badges. In the technical pilot of the refined tools, mean System Usability Scale scores were 81.2/100 for PrEPmate and 76.4/100 for DOT Diary (P=.48), falling in the "good" to "excellent" range, and mean Client Satisfaction Questionnaire scores were 28.6 and 28.3 for PrEPmate and DOT Diary, respectively (maximum possible score=32). Use of both tools was high over the 1-month pilot (average of 10.5 messages received from each participant for PrEPmate; average of 17.6 times accessing the DOT Diary app), indicating good feasibility for both tools.

conclusionsUsing a user-centered design approach, we culturally tailored PrEPmate and DOT Diary to support daily PrEP use among Spanish-speaking MSM and English- and Spanish-speaking transgender women. Our positive findings in a technical pilot support further testing of these mHealth interventions in an upcoming comparative effectiveness trial.

Indexed as

acceptabilityappapplicationdevelopmentformativehealth equityHIVHIV preventionLatinomen who have sex with menmHealthmHealth toolmobile healthmobile technology, mobile apppilotpreexposure prophylaxisPrEPself-managementSMSSpanish-speakingsupporttechnologytext-messagingtooltransgenderUnited StatesUSA

Identifiers

PMID38536232
PMCPMC11007601
OpenAlexW4391409815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.